🇺🇸 FDA
Pipeline program

heme arginate

199/13191

Phase 2 small_molecule completed

Quick answer

heme arginate for Porphyria is a Phase 2 program (small_molecule) at Ultragenyx Pharmaceutical with 3 ClinicalTrials.gov record(s).

Program details

Company
Ultragenyx Pharmaceutical
Indication
Porphyria
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials